thoracotomy
Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial.
Journal of Clinical Oncology 2019 March 28 [Link] Bayman N, Appel W, Ashcroft L, Baldwin DR, Bates A, Darlison L, Edwards JG, Ezhil V, Gilligan D, Hatton M, Jegannathen A, Mansy T, Peake MD, Pemberton L, Rintoul RC, Snee M, Ryder WD, Taylor P, Faivre-Finn C Abstract PURPOSE: Prophylactic irradiation to the chest wall after…
Read More[Clinical and pathological profile of the pleural malignant mesothelioma: A retrospective study about 30 cases].
Revue de Pneumologie Clinique 2018 October 4 [Link] Mlika M, Lamzirbi O, Limam M, Mejri N, Ben Saad S, Chaouch N, Ben Miled K, Marghli A, Mezni F Abstract BACKGROUND: The malignant pleural mesothelioma (MPM) is a rare tumour usually associated to asbestos exposure. The delay between the exposure and the occurrence of the cancer…
Read MoreThe role of surgical intervention in lung cancer with carcinomatous pleuritis
Journal of Thoracic Disease 2016 November [Link] Fukui T, Yokoi K Abstract Patients with non-small cell lung cancer (NSCLC) associated with carcinomatous pleuritis are currently classified as having stage IV disease per the 7th edition of the tumor-node-metastasis (TNM) system, which means that the disease is deemed incurable. In fact, the 5-year survival rate of…
Read MoreAccuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma
Journal of Thoracic Oncology. 2011 Mar;6(3):602-5. [Link] Kao SC, Yan TD, Lee K, Burn J, Henderson DW, Klebe S, Kennedy C, Vardy J, Clarke S, van Zandwijk N, McCaughan BC. Asbestos Diseases Research Institute, Bernie Banton Centre, Sydney, Australia. Abstract Introduction: Histological subtype is an established prognostic factor in malignant pleural mesothelioma (MPM). We retrospectively…
Read More